Refine Your Search
USP supported S. 4090, the “Dietary Supplement Listing Act of 2022.”
Learn More
USP supported the Food and Drug Administration's (FDA's) announcement that it will modernize policies to help ensure the availability of safe, well-manufactured, and appropriately labeled…
Learn More
USP supported FDA regarding the value of public standards as they relate to the integrity of dietary supplements.
Learn More